• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Effects of long term octreotide on gall stone formation and gall bladder function.长期使用奥曲肽对胆结石形成及胆囊功能的影响。
BMJ. 1992 Jun 20;304(6842):1611-2. doi: 10.1136/bmj.304.6842.1611.
2
Differing effects on gall-bladder motility of lanreotide SR and octreotide LAR for treatment of acromegaly.长效兰瑞肽和长效奥曲肽治疗肢端肥大症时对胆囊运动的不同影响。
Eur J Endocrinol. 1999 Dec;141(6):590-4. doi: 10.1530/eje.0.1410590.
3
Effect of octreotide on gall stone prevalence and gall bladder motility in acromegaly.奥曲肽对肢端肥大症患者胆结石患病率及胆囊运动功能的影响。
Gut. 1993 Feb;34(2):270-3. doi: 10.1136/gut.34.2.270.
4
Roles of gall bladder emptying and intestinal transit in the pathogenesis of octreotide induced gall bladder stones.胆囊排空和肠道转运在奥曲肽诱导胆囊结石发病机制中的作用。
Gut. 1996 May;38(5):775-83. doi: 10.1136/gut.38.5.775.
5
Severe impairment of postprandial cholecystokinin release and gall-bladder emptying and high risk of gallstone formation in acromegalic patients during Sandostatin LAR.在使用长效善龙治疗期间，肢端肥大症患者餐后胆囊收缩素释放和胆囊排空严重受损，且胆结石形成风险高。
Aliment Pharmacol Ther. 2001 Feb;15(2):181-5. doi: 10.1046/j.1365-2036.2001.00924.x.
6
Gallbladder function in acromegalic patients taking long-term octreotide: evidence of rebound hypermotility on cessation of treatment.
Scand J Gastroenterol. 1992;27(2):115-8. doi: 10.3109/00365529209165429.
7
Effects of cisapride on gall bladder emptying, intestinal transit, and serum deoxycholate: a prospective, randomised, double blind, placebo controlled trial.西沙必利对胆囊排空、肠道转运及血清脱氧胆酸盐的影响：一项前瞻性、随机、双盲、安慰剂对照试验。
Gut. 2001 Dec;49(6):828-34. doi: 10.1136/gut.49.6.828.
8
Effect of octreotide on fasting gall bladder emptying, antroduodenal motility, and motilin release in acromegaly.奥曲肽对肢端肥大症患者空腹胆囊排空、十二指肠运动及胃动素释放的影响。
Gut. 1995 May;36(5):755-60. doi: 10.1136/gut.36.5.755.
9
Gall stones induced by octreotide.奥曲肽诱发的胆结石
BMJ. 1992 Aug 1;305(6848):313. doi: 10.1136/bmj.305.6848.313.
10
A prospective examination of octreotide-induced gall-bladder changes in acromegaly.
Clin Endocrinol (Oxf). 1992 Mar;36(3):265-9. doi: 10.1111/j.1365-2265.1992.tb01442.x.

引用本文的文献

1
Obesity and Gallstones.肥胖与胆结石
Visc Med. 2021 Oct;37(5):394-402. doi: 10.1159/000515545. Epub 2021 Apr 23.
2
Biliary Tract and Liver Complications in Polycystic Kidney Disease.多囊肾病中的胆道和肝脏并发症
J Am Soc Nephrol. 2017 Sep;28(9):2738-2748. doi: 10.1681/ASN.2017010084. Epub 2017 May 2.
3
Efficacy of 4 Years of Octreotide Long-Acting Release Therapy in Patients With Severe Polycystic Liver Disease.长效奥曲肽治疗4年对重症多囊肝病患者的疗效
Mayo Clin Proc. 2015 Aug;90(8):1030-7. doi: 10.1016/j.mayocp.2015.05.011. Epub 2015 Jul 9.
4
Rare cystic liver lesions: a diagnostic and managing challenge.罕见的肝囊性病变：诊断和处理的挑战。
World J Gastroenterol. 2013 Nov 21;19(43):7603-19. doi: 10.3748/wjg.v19.i43.7603.
5
Somatostatin analog therapy for severe polycystic liver disease: results after 2 years.生长抑素类似物治疗严重多囊肝疾病：2 年后的结果。
Nephrol Dial Transplant. 2012 Sep;27(9):3532-9. doi: 10.1093/ndt/gfs152. Epub 2012 Jul 6.
6
Randomized clinical trial of long-acting somatostatin for autosomal dominant polycystic kidney and liver disease.长作用生长抑素治疗常染色体显性遗传多囊肾病和多囊肝病的随机临床试验。
J Am Soc Nephrol. 2010 Jun;21(6):1052-61. doi: 10.1681/ASN.2009121291. Epub 2010 Apr 29.
7
Phase III, double-blind study of depot octreotide versus placebo in the prevention of acute diarrhea in patients receiving pelvic radiation therapy: results of North Central Cancer Treatment Group N00CA.长效奥曲肽与安慰剂预防盆腔放疗患者急性腹泻的Ⅲ期双盲研究：北中部癌症治疗组N00CA的结果
J Clin Oncol. 2008 Nov 10;26(32):5248-53. doi: 10.1200/JCO.2008.17.1546. Epub 2008 Sep 2.
8
Low serum levels of ghrelin are associated with gallstone disease.血清胃饥饿素水平低与胆结石病有关。
World J Gastroenterol. 2006 May 21;12(19):3096-100. doi: 10.3748/wjg.v12.i19.3096.
9
Epidemiology and risk factors for gallstone disease: has the paradigm changed in the 21st century?胆结石疾病的流行病学及危险因素：21世纪其模式有变化吗？
Curr Gastroenterol Rep. 2005 May;7(2):132-40. doi: 10.1007/s11894-005-0051-8.
10
Treatment options in acromegaly. Benefits and costs.
Pharmacoeconomics. 1996 Nov;10(5):453-9. doi: 10.2165/00019053-199610050-00002.

本文引用的文献

1
Sonographic measurement of gallbladder volume.胆囊容积的超声测量。
AJR Am J Roentgenol. 1985 Nov;145(5):1009-11. doi: 10.2214/ajr.145.5.1009.
2
Postprandial gallbladder motility during long term treatment with the long-acting somatostatin analog SMS 201-995 in acromegaly.
J Clin Endocrinol Metab. 1989 Sep;69(3):557-62. doi: 10.1210/jcem-69-3-557.
3
Therapeutic efficacy of the somatostatin analog SMS 201-995 (octreotide) in acromegaly. Effects of dose and frequency and long-term safety.生长抑素类似物SMS 201-995（奥曲肽）治疗肢端肥大症的疗效。剂量、频率的影响及长期安全性
Ann Intern Med. 1990 Feb 1;112(3):173-81. doi: 10.7326/0003-4819-112-3-173.
4
Long term effect of incremental doses of the somatostatin analog SMS 201-995 in 58 acromegalic patients. French SMS 201-995 approximately equal to Acromegaly Study Group.
J Clin Endocrinol Metab. 1990 Aug;71(2):391-7. doi: 10.1210/jcem-71-2-391.
5
Why does somatostatin cause gallstones?为什么生长抑素会导致胆结石？
Am J Surg. 1991 Jan;161(1):177-82; discussion 182-3. doi: 10.1016/0002-9610(91)90381-m.

Effects of long term octreotide on gall stone formation and gall bladder function.

作者信息

Bigg-Wither G W, Ho K K, Grunstein R R, Sullivan C E, Doust B D

机构信息

Department of Radiology, St Vincent's Hospital, Darlinghurst, New South Wales, Australia.

出版信息

BMJ. 1992 Jun 20;304(6842):1611-2. doi: 10.1136/bmj.304.6842.1611.

DOI:10.1136/bmj.304.6842.1611
PMID:1628089
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1881991/
Abstract
摘要